This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
4 Insurers Set to Outshine Estimates This Earnings Season
by Tanuka De
Better pricing, exposure growth, accelerated digitalization and sturdy capital are expected to help ACGL, ALL, PRU and RGA outperform second-quarter earnings estimates.
Can MetLife (MET) Tackle Lower Premiums in Q2 Earnings?
by Zacks Equity Research
MetLife's (MET) Q2 results are likely to benefit from growing net investment income and a well-performing Latin America segment, partly offset by a fall in overall premiums.
Why Allstate (ALL) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes? Let's find out.
Unum Group (UNM) to Report Q2 Earnings: Here's What to Expect
by Zacks Equity Research
Unum Group's (UNM) second-quarter results are likely to reflect solid persistency in the in-force business, better pricing and improved sales in most of the business segments.
Berkshire Hathaway B (BRK.B) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Berkshire Hathaway B (BRK.B) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ahead of Allstate (ALL) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Allstate (ALL), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.
Is a Beat in Store for Arch Capital (ACGL) in Q2 Earnings?
by Zacks Equity Research
Arch Capital's (ACGL) second-quarter results are likely to reflect growth in invested assets, existing accounts and new business opportunities, partly offset by escalating expenses.
Allstate (ALL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Allstate (ALL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Will Allstate (ALL) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Allstate (ALL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why Allstate (ALL) Gained But Lagged the Market Today
by Zacks Equity Research
Allstate (ALL) concluded the recent trading session at $174.83, signifying a +0.26% move from its prior day's close.
Chubb Limited (CB) Pre-Q2 Earnings Analysis: Should You Sell?
by Tanuka De
Chubb's (CB) second-quarter results are likely to reflect higher catastrophe loss, partly offset by higher premiums driven by rate and exposure increases, and solid new business.
Chubb (CB) Stock Lags Industry YTD: Time to Hold or Fold?
by Tanuka De
Though Chubb's (CB) near-term prospects are weighed down by the recent Baltimore bridge mishap and an overactive hurricane season, the core strength of the insurer offers a ray of hope to investors.
Allstate (ALL) Rises Higher Than Market: Key Facts
by Zacks Equity Research
Allstate (ALL) closed the most recent trading day at $166.91, moving +1.97% from the previous trading session.
Why Allstate (ALL) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes? Let's find out.
Allstate (ALL) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
In the most recent trading session, Allstate (ALL) closed at $159.54, indicating a +0.7% shift from the previous trading day.
Is the Options Market Predicting a Spike in Allstate (ALL) Stock?
by Zacks Equity Research
Investors need to pay close attention to Allstate (ALL) stock based on the movements in the options market lately.
Allstate (ALL) Rises 45% in a Year: Evaluating the Road Ahead
by Zacks Equity Research
Allstate (ALL) remains well-poised for growth on higher P&C insurance premiums, strategic acquisitions and cost-cutting initiatives.
Allstate (ALL) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
Allstate (ALL) concluded the recent trading session at $162.41, signifying a +1.18% move from its prior day's close.
Allstate (ALL) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes? Let's find out.
Why Allstate (ALL) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Discover Financial (DFS) Expands Reach in Singapore With NETS
by Zacks Equity Research
Discover Financial (DFS) accelerates its footprint in Singapore with NETS and enhances cardholder experience.
Allstate (ALL) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Allstate (ALL) concluded the recent trading session at $160.06, signifying a +0.83% move from its prior day's close.
Marsh & McLennan (MMC) Unit Buys Commodity Trading Firm
by Zacks Equity Research
Marsh & McLennan's (MMC) sub-unit, Oliver Wyman, is set to acquire Veritas Total Solutions, enhancing its commodity trading advisory services.
Is Allstate (ALL) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Allstate (ALL) and Credicorp (BAP) have performed compared to their sector so far this year.